ACTIVE INGREDIENT: Pramipexole
STRENGTH & PACK SIZE:
1.05mg Prolonged-Release Tablets x 30 ~ 79107
2.1mg Prolonged-Release Tablets x 30 ~ 79108
Prapexin is indicated in adults for treatment of the signs and symptoms of idiopathic Parkinson’s disease, alone (without levodopa) or in combination with levodopa, i.e. over the course of the disease, through to late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or “on off” fluctuations).